Lupus: Open Access
Open Access

Department of Pathophysiology, East Africa University, Bosaso, Somalia

Publications

• Commentary   
  Overview, Daignosis and Treatment of Lupus Anticoagulant Syndrome
  Author(s): Ryes Andrew*
  
  Lupus anticoagulants are a diverse class of immunoglobulins that particularly target epitopes that are part of the negative-charged phospholipid binding protein of the cell membrane, prothrombin, and beta2-GPI, inhibiting phospholipid-dependent coagulation invitro. Antiphospholipid syndrome is an uncommon autoimmune condition characterised by the formation of blood clots in numerous regions of the body. Because it is more common in patients with lupus, it is also known as lupus anticoagulant syndrome... View More»
  DOI: 10.35248/2684-1630.23.8.242

  Abstract HTML PDF